Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Norte, RN 59012-570 Natal, Brazil.
Bioanalysis and Molecular Biotechnology Laboratory, Federal University of Rio Grande do Norte, RN 59012-570 Natal, Brazil.
Int J Mol Sci. 2020 Dec 31;22(1):346. doi: 10.3390/ijms22010346.
Colorectal cancer (CRC) is one of the most common malignant tumors in the gastrointestinal tract. It is a multifactorial disease that involves environmental factors, genetic factors, and lifestyle factors. Due to the absence of specific and sensitive biomarkers, CRC patients are usually diagnosed at an advanced stage and consequently suffer from a low 5-year overall survival rate. Despite improvements in surgical resection and adjuvant chemotherapy, the prognosis of patients with CRC remains unfavorable due to local and distant metastases. Several studies have shown that small noncoding RNAs, such as microRNAs packed in exosomes, are potential biomarkers in various types of cancers, including CRC, and that they can be detected in a stable form in both serum and plasma. In this review, we report the potential of circulating exosomal miRNAs to act as biomarkers for the diagnosis and prognosis of CRC.
结直肠癌(CRC)是胃肠道最常见的恶性肿瘤之一。它是一种多因素疾病,涉及环境因素、遗传因素和生活方式因素。由于缺乏特异性和敏感性生物标志物,CRC 患者通常在晚期诊断,因此 5 年总生存率较低。尽管手术切除和辅助化疗有所改善,但由于局部和远处转移,CRC 患者的预后仍然不佳。几项研究表明,小的非编码 RNA,如包裹在 exosomes 中的 microRNAs,是包括 CRC 在内的各种癌症的潜在生物标志物,并且可以在血清和血浆中以稳定的形式检测到。在这篇综述中,我们报告了循环 exosomal miRNAs 作为 CRC 诊断和预后生物标志物的潜力。